DRW Securities’s bluebird bio BLUE Stock Holding History

DRW Securities’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,732	Closed	-$3.78M	–	82
2015 Q2	$3.78M	Buy	+1,732	New	+$3.53M	0.41%	13

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DRW Securities's BLUE Position: Q3 2015 in Review

DRW Securities sold out of bluebird bio (BLUE) in Q3 2015, closing a stake of 1,732 shares — an estimated $3.78M sold.

DRW Securities first reported a position in BLUE in Q2 2015 and held it in 1 quarter. The position peaked at $3.78M in Q2 2015. 192 funds tracked by Wall St. Rank hold BLUE as of Q3 2015.

DRW Securities reported no remaining bluebird bio position as of Q3 2015 after selling out during the quarter.
DRW Securities sold 1,732 bluebird bio shares in Q3 2015, an estimated $3.78M.
DRW Securities first reported a position in bluebird bio in Q2 2015 and held it in 1 quarter.
DRW Securities's bluebird bio position peaked at $3.78M in Q2 2015.
192 funds tracked by Wall St. Rank held bluebird bio as of Q3 2015.

Based on DRW Securities's 13F filing for Q3 2015, filed 16 Nov 2015.